The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Lineage Cell Therapeutics Inc (AMEX: LCTX) closed at $0.54 in the last session, down -1.91% from day before closing price of $0.55. In other words, the price has decreased by -$1.91 from its previous closing price. On the day, 0.89 million shares were traded. LCTX stock price reached its highest trading level at $0.55 during the session, while it also had its lowest trading level at $0.5303.
Ratios:
We take a closer look at LCTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.48 and its Current Ratio is at 2.48. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on August 20, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On November 02, 2022, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $5.
On June 14, 2022, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.B. Riley Securities initiated its Buy rating on June 14, 2022, with a $4 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when Howe Jill Ann bought 15,000 shares for $0.59 per share. The transaction valued at 8,850 led to the insider holds 25,500 shares of the business.
Samuel George A. III bought 15,000 shares of LCTX for $9,000 on Nov 26 ’24. The General Counsel now owns 22,184 shares after completing the transaction at $0.60 per share. On Nov 22 ’24, another insider, Mulroy Michael H., who serves as the Director of the company, bought 40,000 shares for $0.57 each. As a result, the insider paid 22,640 and bolstered with 298,555 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LCTX now has a Market Capitalization of 118583808 and an Enterprise Value of 130151080. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.34 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 21.04 whereas that against EBITDA is -6.083.
Stock Price History:
Over the past 52 weeks, LCTX has reached a high of $1.61, while it has fallen to a 52-week low of $0.48. The 50-Day Moving Average of the stock is -25.65%, while the 200-Day Moving Average is calculated to be -43.52%.
Shares Statistics:
According to the various share statistics, LCTX traded on average about 1.72M shares per day over the past 3-months and 2408380 shares per day over the past 10 days. A total of 220.42M shares are outstanding, with a floating share count of 218.96M. Insiders hold about 0.66% of the company’s shares, while institutions hold 43.57% stake in the company. Shares short for LCTX as of 1730332800 were 15938784 with a Short Ratio of 13.32, compared to 1727654400 on 15221739. Therefore, it implies a Short% of Shares Outstanding of 15938784 and a Short% of Float of 10.89.
